SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fredun Pharmaceuticals forays into large animal veterinary segment

12 Mar 2025 Evaluate

Fredun Pharmaceuticals has forayed into the large animal veterinary segment, under the FREOSSI Large Animals brand with the launch of targeted products Freossi Tone+ and Freossi Power. FREOSSI has a strong & existing reputation in companion animal care, hence this will provide a foundation of trust and reliability when expanding into large animal products. These new products have scientific & clinical evidence and are developed with the expertise of veterinary professionals in animal health. They specifically are designed to address key health challenges faced by livestock owners including lactation issues, quality of milk, joint stiffness, and mobility concerns.

A scientifically formulated supplement, Freossi Tone+ supports higher milk yield & better milk quality, improved lactation cycles, and overall skeletal and muscular health. Enriched with Microcrystalline Hydroxyapatite Complex (MCHC), proteins, collagens, and a proprietary blend with evaluated ratios of herbal extracts, it is ideal for cows, buffaloes, goats, and horses. Freossi Power is designed to alleviate joint stiffness, lameness, and inflammation in large animals. Its active ingredients Microcrystalline Hydroxyapatite Complex (MCHC) including Glucosamine Sulphate USP and Methylsulfonylmethane (MSM), support joint health, flexibility, and endurance, making it ideal for horses, bulls, ponies, and cattle. 

Fredun Pharmaceuticals is engaged in manufacturing of pharmaceutical products.


Fredun Pharma Share Price

2020.00 -47.70 (-2.31%)
21-Apr-2026 14:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1671.20
Dr. Reddys Lab 1220.40
Cipla 1233.30
Zydus Lifesciences 930.70
Lupin 2314.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×